
Intelligent Management Holding, the founder and shareholder of EFES Insurance Company and the Vardanants Innovative Medical Center, has launched a second tranche of bonds worth 3 billion drams with a yield of 11.7 per cent per annum. Ameriabank is serving as underwriter, as it did for the debut issue. The public offering opened on 18 May 2026 and runs through 31 August or until fully subscribed.
Roughly $7.7 million at prevailing rates, the tranche is small by international standards and unremarkable by the standards of a developed corporate debt market. In the Armenian context it is neither. The domestic corporate bond market remains thin, dominated by bank issuance, and repeat issuance by a non-financial holding company with a named underwriter is a structural development worth tracking.
The pricing tells the story. An 11.7 per cent dram yield sits materially above the Central Bank of Armenia's policy rate and reflects a combination of inflation expectations, currency risk premium and issuer-specific credit spread. For domestic investors holding dram-denominated savings, it is a competitive alternative to bank deposits. For the issuer it is expensive money, which implies either that bank credit was unavailable at better terms or that the holding is deliberately diversifying its funding base away from bilateral lending.
The second reading is the more interesting one. Armenian corporates have been almost entirely bank-financed, which concentrates systemic risk and caps the growth of any business whose expansion outpaces its lender's appetite. A holding company that can return to the public market for a second tranche has established something closer to a funding programme, and Ameriabank's willingness to underwrite twice signals confidence in the distribution.
The underlying assets are defensive. Insurance and private healthcare are both sectors with recurring revenue and relatively predictable cash generation, which suits a debt structure. The Armenian insurance market has been consolidating and professionalising, with LIGA Insurance among those refreshing brand identity and pursuing international integration after eighteen years of operation.
Investors should weigh the constraints honestly. Armenian corporate credit lacks independent rating coverage, secondary market liquidity for these instruments is minimal, and an 11.7 per cent coupon implies real risk rather than a free lunch. Currency exposure is the dominant variable for any non-dram holder. But the broader signal is that Armenia's capital markets are beginning to perform a function beyond deposit-taking, and that is a precondition for the kind of private investment the country's growth narrative requires.